Peter Smits, ESC 2021 – High Bleeding Risk After Coronary Stenting
Dr Peter Smits (Interventional Cardiologist, Maasstad Hospital, Rotterdam, The Netherlands) kindly shared his thoughts on the major challenges in the treatment of patients at high bleeding risk after coronary stenting, with an overview of the recent key clinical trials involving percutaneous coronary intervention with stent deployment in patients at high bleeding risk, from the virtual ESC Congress 2021.
- What are the major challenges in the management of patients at high bleeding risk after coronary stenting? (0.12)
- How has the identification of patients at high bleeding risk improved in recent years and what challenges remain? (0.30)
- Could you give us an overview of the recent key clinical trials involving percutaneous coronary intervention (PCI) with stent deployment in patients at high bleeding risk? (1.41)
- What factors should be considered when selecting antiplatelet and antithrombotic strategies for patients following PCI? (3.59)
- What questions remain unanswered and what does the future hold? (4.47)
Speaker disclosures: Dr Peter Smits wishes to declare from the last 12 months: receipt of institutional research grants from Abbott Vascular and SMT, receipt of consultancy and speaker’s fees from Terumo, Abbott Vascular, Abiomed, Microport and AstraZeneca.
Support: Interview and filming supported by Touch Medical Media and conducted by Heather Hall.
Filmed during a remote video call with Dr Peter Smits as a highlight of ESC 2021, August 2021.
Share this Video
Related Videos In Interventional Cardiology
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
Hyo-Soo Kim, ACC 2023: Guidelines for the use of short-term dual antiplatelet therapy after coronary intervention
The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient’s clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea) to discuss the current guidelines for the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!